Cecilia obtained her Msc in Cellular and Molecular Biology in 2020 at the University of Turin, where she studied ischemia-reperfusion mechanisms in ex vivo and in vitro cardiovascular models. She is currently a PhD student in Molecular Experimental Medicine at Humanitas University. Her project focuses on genetic cardiomyopathies – mainly due to mutations in Titin and Lamin A/C proteins – with the aim to develop personalized cellular platforms to identify new prognostic markers and therapeutic strategies for patients affected by this group of diseases.

Her work is based on cardiomyocytes differentiated from induced Pluripotent Stem Cells, to specifically test reliability of iPSC-derived models in reproducing patients clinical phenotypes and response to drugs using functional and molecular assays.